SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
SINGAPORE, Dec. 18, 2025 /PRNewswire/ -- UTI Investments announced that its Sovereign Bond ETF (Bloomberg Ticker: UIGB NA Equity) offered under a Restricted Scheme...
SINGAPORE, Dec. 18, 2025 /PRNewswire/ -- Whalet, a leading payment provider specializing in cross-border financial services, has inked an agreement with OCBC, Southeast Asia's...